An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin (TM)) [ASCENT]
Stephen Clarke, Matt Burge, Cassandra Cordwell, Peter Gibbs, William Reece, Niall Tebbutt
BMC Cancer | BMC | Published : 2013
The study is sponsored by Roche Products, Pty. Limited (Australia). Medical witting assistance was provided by Dr Joseline Ojaimi from Roche. We would like to thank the clinical research team at Roche, the investigation sites and all the patients who will participate in this study and their families.